CompletedNCT00345982
Sertindole or placebo added to clozapine for treatment-resistant schizophrenia
About this title
Read the official source — NCT00345982Medication studyAges 18–65Denmark
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- AalborgSee all locations and recruitment
Study information
Study start dateSeptember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- University of Aarhus
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Denmark
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00345982
- Official title
Show the full official title
Augmenting Clozapine With Sertindole - a Double Blinded Randomized Placebo Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aalborg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Aarhus, a university.
Did this study involve medication?
Yes. The study involved medication, including Serdolect and placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Pa...
A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of iclepertin once daily over 26 week treatment period in patients with schizophreni...